Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial Muhammad Atif Habib, MPH, Sajid Soofi, FCPS, Prof Simon Cousens, DipMathStat, Saeed Anwar, MPH, Najib ul Haque, FRCP, Imran Ahmed, MSc, Noshad Ali, MPH, Rehman Tahir, MBA, Prof Zulfiqar A Bhutta, PhD The Lancet Global Health Volume 5, Issue 6, Pages e593-e603 (June 2017) DOI: 10.1016/S2214-109X(17)30184-5 Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
Figure 1 Map of Pakistan showing study areas FATA=Federally Administered Tribal Areas. KPK=Khyber Pakhtunkhwa. AJK=Azad Jammu and Kashmir. The Lancet Global Health 2017 5, e593-e603DOI: (10.1016/S2214-109X(17)30184-5) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
Figure 2 Trial profile The Lancet Global Health 2017 5, e593-e603DOI: (10.1016/S2214-109X(17)30184-5) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
Figure 3 OPV coverage by rounds OPV=oral polio vaccine. IPV=inactivated polio vaccine. The Lancet Global Health 2017 5, e593-e603DOI: (10.1016/S2214-109X(17)30184-5) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions